What histopathologic features on a labial salivary gland biopsy confirm Sjögren syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Histopathology of Labial Salivary Gland Biopsy in Sjögren Syndrome

The diagnostic hallmark on labial salivary gland biopsy is focal lymphocytic sialadenitis (FLS) with a focus score ≥1, defined as ≥1 focus per 4 mm² of glandular tissue, where each focus contains ≥50 mononuclear cells (predominantly lymphocytes) in periductal or perivascular distribution. 1

Key Diagnostic Features

Primary Criterion: Focal Lymphocytic Sialadenitis (FLS)

The most characteristic histopathologic feature has >80% sensitivity and specificity for primary Sjögren syndrome 1. The diagnosis requires:

  • Dense aggregates (foci) of lymphocytes
  • ≥50 mononuclear cells per focus (mostly lymphocytes)
  • Periductal or perivascular localization
  • Adjacent to normal-appearing acini 1

Focus Score Calculation

Focus Score ≥1 is the diagnostic threshold used in ACR/EULAR classification criteria 1, 2:

  • Count all foci containing ≥50 mononuclear cells
  • Divide by total glandular surface area in mm²
  • Multiply by 4 to express as foci per 4 mm²
  • Example: 8 foci in 20.89 mm² = (8/20.89) × 4 = Focus Score of 1.53 1

Critical technical point: Focus score ≥1 strongly associates with anti-SSA/SSB positivity (9-fold increased likelihood) and ocular manifestations, confirming this reflects true SS autoimmunity rather than nonspecific inflammation 3.

Additional Histopathologic Features

Secondary Features to Report

While FLS with focus score ≥1 is diagnostic, additional features have prognostic significance 1:

Lymphoepithelial Lesions (LESA):

  • Lymphocytic infiltration of ducts
  • Basal cell hyperplasia creating multilayered epithelium
  • May indicate more aggressive disease

Germinal Centers (GCs):

  • Organized lymphoid structures
  • More common in parotid than labial glands 4
  • Associated with B-lymphocyte activity

Chronicity Features (significantly more common in SS patients) 2:

  • Acinar atrophy
  • Ductal dilatation
  • Fibrosis
  • Important caveat: These can occur without lymphocytic infiltration in some SS cases 2

Critical Distinction: FLS vs. Nonspecific Chronic Sialadenitis

You must distinguish FLS from nonspecific chronic sialadenitis (NSCS) before calculating focus score 3. This is essential because:

  • NSCS shows atrophy and duct dilation common in general population
  • NSCS may have lymphocytic infiltration but lacks organized foci
  • Only FLS with focus score ≥1 strongly associates with SS autoimmunity 3

Technical Requirements for Valid Interpretation

Adequate Tissue Sample

Obtain 4 labial salivary glands to ensure:

  • Minimum 8 mm² glandular surface area 1
  • Sufficient material to overcome atrophic or damaged glands
  • Reliable focus score, especially with borderline results

Report the actual surface area examined for clinical interpretation 1.

Tissue Processing

  • Formalin-fixed, paraffin-embedded sections
  • H&E staining for routine assessment
  • Measure only glandular tissue (exclude epithelial/connective tissue) 1
  • Include interspersed atrophic areas in glandular measurement 1

Common Pitfalls and How to Avoid Them

Pitfall #1: Counting foci in areas of NSCS rather than adjacent to normal acini

  • Solution: SICCA protocol specifies foci must be adjacent to normal-appearing acini 1

Pitfall #2: Inadequate tissue sample leading to false negatives

  • Solution: Ensure ≥8 mm² glandular tissue; consider additional cutting levels at 200 μm intervals if borderline 1

Pitfall #3: Prior immunosuppressive therapy masking histologic changes

  • Solution: Obtain biopsy early in diagnostic workup before treatment initiation 5

Pitfall #4: Confusing partially confluent foci

  • Solution: Consider measuring total infiltrated area in addition to focus score for clinical trials 1

Clinical Correlation

The 80% of cases with focus score ≥1 among those with FLS demonstrates strong diagnostic utility 1. However, recognize that:

  • Focus score ≥1 associates with serologic markers (anti-SSA/SSB, RF) and ocular dryness 3
  • No significant association with subjective dry mouth/eye symptoms 3
  • Patients with unstimulated salivary flow <0.1 ml/min are 2× more likely to have focus score ≥1 3

Integration with Other Diagnostic Modalities

LSGB should not serve as standalone diagnostic tool 6. Integrate with:

  • Serologic testing (ANA, anti-SSA/Ro, anti-La/SSB)
  • Ocular testing (Schirmer's test, ocular staining)
  • Salivary flow measurements
  • Consider salivary gland ultrasonography for early/seronegative cases 6

The presence of other autoimmune diseases significantly associates with positive LSGB findings 6, supporting the systemic autoimmune nature of the disease.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.